...
首页> 外文期刊>Journal of Ethnopharmacology: An Interdisciplinary Journal Devoted to Bioscientific Research on Indigenous Drugs >Efficacy and safety of Xuebijing injection (a Chinese patent) for sepsis: A meta-analysis of randomized controlled trials
【24h】

Efficacy and safety of Xuebijing injection (a Chinese patent) for sepsis: A meta-analysis of randomized controlled trials

机译:肠炎注射(中国专利)对败血症的疗效和安全性:随机对照试验的荟萃分析

获取原文
获取原文并翻译 | 示例
           

摘要

Ethnopharmacological relevance: Xuebijing injection (XBJ), a Chinese patent medicine that was approved for treating sepsis in China in 2004, consists of Carthamus tinctorius L. (Carthami Flos, hong hua), Paeonia lactiflora Pall. (Paeoniae Radix Rubra, chi shao), Ligusticum chuanxiong Hort. (Chuanxiong Rhizoma, chuan xiong), Salvia miltiorrhiza Bge. (Salviae Miltiorrhizae Radix Et Rhizoma, dan Shen) and Angelica sinensis (Oliv.) Diels (Angelicae Sinensis Radix, dang gui).
机译:民族科科医生相关性:Xuebijing注射(XBJ)是2004年批准治疗中国败血症的中国专利医学,包括Carthamus Tinctorius L.(Carthami Flos,Hong Hua),Paeonia Lactiflora Pall。 (Paeoniae Radix Rubra,Chi Shao),Ligusticum Chuanxiong Hort。 (川芎雄黄,川雄),丹参米尔蒂氏珠博士。 (Salviae Miltiorrhizae Radix et Rhizoma,Dan Shen)和Angelica Sinensis(Oliv。)Diels(Angelicae Sinensis Radix,Dang GUI)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号